Published in Science on August 23, 1918
ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst (1992) 2.54
Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods (1995) 1.76
Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol (1989) 1.54
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system. Cytotherapy (2006) 1.41
Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood (1996) 1.29
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22
Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23. J Immunol (1985) 1.09
Trisomy 13: a new recurring chromosome abnormality in acute leukemia. Blood (1990) 1.07
Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk. Leukemia (2006) 1.06
Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol). J Immunol (1984) 1.05
Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity. Proc Natl Acad Sci U S A (1982) 1.04
Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis. Blood (1984) 1.01
Heterogeneity of clonogenic cells in acute myeloblastic leukemia. J Clin Invest (1985) 1.00
Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med (1980) 1.00
An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood (1997) 0.98
Ovarian recovery after stem cell transplantation. Bone Marrow Transplant (2007) 0.97
Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res (1996) 0.96
Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J Clin Invest (1984) 0.94
Immune markers in hematologic malignancies. Crit Rev Oncol Hematol (1991) 0.91
Glucocorticoid enhances gamma interferon effects on human monocyte antigen expression and ADCC. Clin Exp Immunol (1986) 0.91
Optimal use of G-CSF administration after hematopoietic SCT. Bone Marrow Transplant (2009) 0.91
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma. Bone Marrow Transplant (2004) 0.90
Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia. Blood (1983) 0.89
Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies. Bone Marrow Transplant (1996) 0.89
The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation. Blood (1983) 0.89
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells. Blood (1985) 0.89
Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia (1998) 0.89
Regulation of p21(WAF1) expression during normal myeloid differentiation. Blood (1998) 0.89
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies. Blood (1986) 0.88
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study. Am J Hematol (1995) 0.86
The expression and modulation of human myeloid-specific antigens during differentiation of the HL-60 cell line. Blood (1983) 0.86
Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine. Eur J Immunol (1989) 0.85
Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program. Bone Marrow Transplant (2012) 0.85
Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period. Clin Cancer Res (1995) 0.85
Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support. Int J Breast Cancer (2011) 0.84
Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon. Cancer Res (1986) 0.84
Induction of differentiation in blast cells and leukemia colony-forming cells from patients with acute myeloid leukemia. Blood (1990) 0.83
Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells. J Immunol (1982) 0.82
Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation (1995) 0.82
1,25-Dihydroxyvitamin D3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line. Mol Immunol (1985) 0.82
Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice. J Hematother Stem Cell Res (2001) 0.81
Monoclonal antibodies reactive with human myeloid leukaemia cells. Clin Exp Immunol (1982) 0.81
Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion. Bone Marrow Transplant (2001) 0.81
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets. Br J Haematol (1996) 0.80
A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody. J Immunol (1983) 0.80
Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years. Bone Marrow Transplant (1997) 0.80
The use of myeloid-specific monoclonal antibodies in the diagnosis of leukemia. Diagn Immunol (1983) 0.80
Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood (1994) 0.80
Monoclonal antibodies PMN 6, PMN 29, and PM-81 bind differently to glycolipids containing a sugar sequence occurring in lacto-N-fucopentaose III. Arch Biochem Biophys (1984) 0.79
Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon. Cancer Immunol Immunother (1986) 0.79
Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant (1994) 0.79
Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells. Cytotherapy (2004) 0.79
Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA. Gene Ther (1994) 0.79
Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells. Leuk Res (2001) 0.79
Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene. Gene Ther (1994) 0.78
Idiotypic determinants of monoclonal antibodies that bind to 3-fucosyllactosamine. J Immunol (1986) 0.78
Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation. Am J Hematol (1989) 0.78
Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor. Br J Haematol (1995) 0.78
Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu model. Leuk Res (1996) 0.77
Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads. Cancer Res (1990) 0.77
Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64). Clin Cancer Res (1995) 0.77
Autologous bone marrow transplantation in the treatment of acute myeloid leukemia: the Dartmouth experience and a review of literature. Cancer Invest (1990) 0.77
Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (1997) 0.77
Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells. Eur J Haematol (1998) 0.76
Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells. Br J Haematol (1995) 0.76
FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia. Bone Marrow Transplant (2003) 0.76
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation. Cytotherapy (2000) 0.76
Thy-1 expression on blast cells from adult patients with acute myeloid leukemia. Leuk Res (1997) 0.76
A unique population of CD34+ cells in cord blood. Stem Cells (1995) 0.76
Xenotransplantation of hematopoietic cells resistant to HIV as a potential treatment for patients with AIDS. Transplant Proc (1994) 0.75
Ex vivo purging and cell expansion. J Hematother Stem Cell Res (1999) 0.75
Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. Cancer Res (1991) 0.75
Immunotoxins for ex vivo marrow purging in autologous bone marrow transplantation for acute nonlymphocytic leukemia. Transplantation (1988) 0.75
Purging marrow or peripheral blood stem cells for autografting. Curr Opin Hematol (1997) 0.75
Predictive value of flow cytometric analyses of blast cells in assessing the phenotype of the leukemia colony-forming cell (L-CFC) population in acute myeloid leukemia. Bone Marrow Transplant (1992) 0.75
Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells. Exp Hematol (1988) 0.75
Sialylated glycolipid antigens on human leukemic cell lines. Exp Hematol (1986) 0.75
Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemia. Med Pediatr Oncol (1988) 0.75
Methods for Retrovirus-Mediated Gene Transfer to CD34(+) Enriched Cells. Methods Mol Med (1997) 0.75
AGRICULTURAL RESEARCH AS A CAREER. Science (1923) 0.75
Efficacy of bone marrow purging in AML using monoclonal antibodies and complement. Prog Clin Biol Res (1990) 0.75
Purging autologous bone marrow with monoclonal antibodies for transplantation in acute myelogenous leukemia. Blood Rev (1997) 0.75
Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow. Bone Marrow Transplant (1992) 0.75
A novel monoclonal antibody, SCCL 175, with specificity for small cell neuroendocrine carcinoma of the lung. Cancer Res (1988) 0.75
Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells. Bone Marrow Transplant (1989) 0.75
Isodicentric chromosome 18q as sole abnormality in a histologically normal bone marrow from a patient with diffuse large-cell non-Hodgkin's lymphoma. Cancer Genet Cytogenet (1991) 0.75
Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis. Blood (1985) 0.75
Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line. Exp Hematol (1986) 0.75
Characterization of a new monoclonal antibody 6G7 that recognizes a unique antigen on myeloid and lymphoid cells. J Hematother Stem Cell Res (2001) 0.75
A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells. J Hematother (1996) 0.75
Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen. J Immunol (1999) 0.75
BIOLOGICAL ABSTRACTS. Science (1923) 0.75
A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells. J Hematother (1994) 0.75
BIOLOGICAL ABSTRACTS. Science (1924) 0.75
Magnetic affinity colloid (MAC) cell separation of leukemia cells from autologous bone marrow aspirates. Leuk Res (1987) 0.75
Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support. Clin Oncol (R Coll Radiol) (2001) 0.75
A PUZZLING BUTTERFLY MIGRATION. Science (1928) 0.75